SLS Sellas Life Sciences Group Inc
Company Analysis
Latest News
🟢 Sellas Life Sciences is trading 4.3% up today amid broad market strength
Sellas Life Sciences is trading at $12.01, up 4.34%, amid broad market strength. - Broader markets are higher, with the Nasdaq up 0.94%; this may be...
SELLAS Shares Rally 167% YTD, Drawing Valuation Questions After SLS009 Data
SELLAS Life Sciences drew fresh attention after presenting new preclinical data on its CDK9 inhibitor, SLS009, in pancreatic cancer models at the AACR...
🟢 Sellas Life Sciences is trading 4.04% up today
Sellas Life Sciences is trading at $11.98, up 4.04%, rebounding after September 23’s decline; no clear catalyst for today’s gain was identified. - Shares fell...
🔴 Sellas Life Sciences is trading 4.01% down today amid broad U.S. equity weakness
Sellas Life Sciences is trading 4.01% lower at $11.54, primarily amid broad U.S. equity weakness on September 23, 2026. - The Nasdaq fell 1.02%, the S&P 500...
🟢 Sellas Life Sciences rises 4.3% — Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is trading higher, driven by a...
🔴 Sellas Life Sciences is trading 5% down in pre-market amid reported 80th patient-death event, no results
Sellas Life Sciences is trading now at $11.05, down 5.23%, amid continued investor concern surrounding its Phase 3 REGAL trial and the timing of topline...
🔴 Sellas Life Sciences falls 4.4% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Sellas Life Sciences is trading 4.37% up today — no verified company-specific catalyst
Sellas Life Sciences is trading 4.37% up now at $12.05, rebounding after its 14.42% decline on September 11, 2026; no verified company-specific catalyst...
🔴 Sellas Life Sciences is trading 10% down in pre-market ahead of Tuesday’s Federal Reserve decision
Sellas Life Sciences is trading 10.39% down at $10.35, with the decline appearing aligned with broader risk-off sentiment ahead of the Federal Reserve...
🔴 Sellas Life Sciences is trading 5.8% down in pre-market ahead of Tuesday’s Federal Reserve decision
Sellas Life Sciences is trading 5.8% down now at $10.88, with the decline appearing consistent with broader risk-off trading ahead of Tuesday’s Federal Reserve...
🔴 Sellas Life Sciences is trading 11.05% down today with no clear company-specific catalyst
Sellas Life Sciences is trading 11.05% down now at $12.00 after no clear company-specific catalyst emerged on September 11, 2026. - The latest identified...
🔴 Sellas Life Sciences is trading 4.37% down today with no clear catalyst identified
Sellas Life Sciences is trading 4.37% down now at $12.90 after no clear company-specific catalyst emerged in available September 11, 2026 coverage. - The...
Sellas Life Sciences faces investigation, stock sinks 13% on delayed trial results
Bronstein, Gewirtz & Grossman, LLC is investigating potential legal claims for Sellas Life Sciences investors. The probe follows an August 28, 2026, report...
🟢 Sellas Life Sciences is trading 4.12% up today after three SLS009 abstracts accepted for 2026 AACR
Sellas Life Sciences is trading 4.12% up at $13.77 after announcing on September 2, 2026, that three abstracts evaluating SLS009 in pancreatic cancer models...
🔴 Sellas Life Sciences is trading 4.27% down today as biotech sector falls
Sellas Life Sciences is trading 4.27% down at $12.77, broadly in line with the biotechnology sector, which is down 4.24% during the regular session. - No new...
🔴 Sellas Life Sciences is trading 10.22% down today as REGAL leukemia trial optimism fades
Sellas Life Sciences is trading 10.22% down at $13.65 as investors reverse recent enthusiasm surrounding the REGAL leukemia trial. - No fresh company-specific...
🔴 Sellas Life Sciences is trading 5.5% down today — no fresh company explanation identified
Sellas Life Sciences is trading 5.5% down at $14.38, with no fresh company announcement identified to explain the August 28, 2026 decline. - Recent coverage...
Sellas Life Sciences Rallies, Following ARK Invest’s Cancer Vaccine Endorsement
Sellas Life Sciences shares gained momentum on August 27, 2026. Cathie Wood’s ARK Investment Management highlighted the growth potential of the personalized...
Sellas Stock Jumps 7% on Unverified Leukemia Trial Milestone — But Can Investors Trust a Rumor With This Much at Stake?
Shares of Sellas Life Sciences surged 7.1% to $14.70 on August 27 after an unconfirmed report — originating from a German source — claimed the company's...
🟢 Sellas Life Sciences is trading 10.12% up today on unconfirmed REGAL 80th-event report
Sellas Life Sciences is trading 10.12% up now at $15.12 after renewed attention to an unconfirmed report that the Phase 3 REGAL leukemia trial reached its...